Abstract
We describe successful induction of immune tolerance in a 12-month-old patient with severe haemophilia B and low-titre and low response antifactor IX inhibitor at 5 Bethesda Unit (BU). Immune tolerance induction (ITI) was started with recombinant factor (rFIX) at 40-50 U kg(-1) day(-1) (1000 U three times per week) and 2 years after the beginning of therapy the inhibitor had been reduced to undetectable values. As complications, which appeared during the ITI, the patient presented minor haemorrhagic complications, which remitted following the administration of rFVIIa, and recurring infections of the catheter, requiring the withdrawal and subsequent placement of a new catheter.
References
Jan 1, 1991·The American Journal of Pediatric Hematology/oncology·P PetriniM Blombäck
Sep 1, 1995·British Journal of Haematology·R J LiesnerJ S Lilleymann
Mar 1, 1996·British Journal of Haematology·R J LiesnerI M Hann
Jan 5, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·I Warrier
Feb 24, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·L TengbornR Ljung
Aug 12, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·I ScharrerO Neutzling
Oct 26, 1999·Vox Sanguinis·H Lenk
May 23, 2000·Lancet·B Dahlbäck
Mar 22, 2001·Haemophilia : the Official Journal of the World Federation of Hemophilia·S HayaUNKNOWN Spanish Immune Tolerance Group
Feb 20, 2002·Haemophilia : the Official Journal of the World Federation of Hemophilia·M MoradoF Hernandez-Navarro
May 16, 2002·Haemophilia : the Official Journal of the World Federation of Hemophilia·J Tusell, R Pérez-Bianco
Apr 16, 2003·Haemophilia : the Official Journal of the World Federation of Hemophilia·N SuzukiH Tsutsumi
Apr 24, 2003·Haemophilia : the Official Journal of the World Federation of Hemophilia·E Berntorp
Apr 24, 2003·Haemophilia : the Official Journal of the World Federation of Hemophilia·J Astermark